References
- National Lung Screening Trial Research Team, Church TR, Black WC, Aberle DR, Berg CD, Clingan KL, et al. Results of initial low-dose computed tomographic screening for lung cancer. N Engl J Med 2013;368:1980-1991 https://doi.org/10.1056/NEJMoa1209120
- Hoffman JM, Gambhir SS. Molecular imaging: the vision and opportunity for radiology in the future. Radiology 2007; 244:39-47 https://doi.org/10.1148/radiol.2441060773
- Bomanji JB, Costa DC, Ell PJ. Clinical role of positron emission tomography in oncology. Lancet Oncol 2001;2:157-164 https://doi.org/10.1016/S1470-2045(00)00257-6
- Cornelis F, Silk M, Schoder H, Takaki H, Durack JC, Erinjeri JP, et al. Performance of intra-procedural 18-fluorodeoxyglucose PET/CT-guided biopsies for lesions suspected of malignancy but poorly visualized with other modalities. Eur J Nucl Med Mol Imaging 2014;41:2265-2272 https://doi.org/10.1007/s00259-014-2852-1
- Klaeser B, Mueller MD, Schmid RA, Guevara C, Krause T, Wiskirchen J. PET-CT-guided interventions in the management of FDG-positive lesions in patients suffering from solid malignancies: initial experiences. Eur Radiol 2009;19: 1780-1785 https://doi.org/10.1007/s00330-009-1338-1
- Guralnik L, Rozenberg R, Frenkel A, Israel O, Keidar Z. Metabolic PET/CT-guided lung lesion biopsies: impact on diagnostic accuracy and rate of sampling error. J Nucl Med 2015; 56:518-522 https://doi.org/10.2967/jnumed.113.131466
- Purandare NC, Kulkarni AV, Kulkarni SS, Roy D, Agrawal A, Shah S, et al. 18F-FDG PET/CT-directed biopsy: does it offer incremental benefit? Nucl Med Commun 2013;34:203-210 https://doi.org/10.1097/MNM.0b013e32835c5a57
- Stattaus J, Kuehl H, Ladd S, Schroeder T, Antoch G, Baba HA, et al. CT-guided biopsy of small liver lesions: visibility, artifacts, and corresponding diagnostic accuracy. Cardiovasc Intervent Radiol 2007;30:928-935 https://doi.org/10.1007/s00270-007-9023-8
- Gelbman BD, Cham MD, Kim W, Libby DM, Smith JP, Port JL, et al. Radiographic and clinical characterization of false negative results from CT-guided needle biopsies of lung nodules. J Thorac Oncol 2012;7:815-820 https://doi.org/10.1097/JTO.0b013e31824abd9c
- Hiraki T, Mimura H, Gobara H, Iguchi T, Fujiwara H, Sakurai J, et al. CT fluoroscopy-guided biopsy of 1,000 pulmonary lesions performed with 20-gauge coaxial cutting needles: diagnostic yield and risk factors for diagnostic failure. Chest 2009;136:1612-1617 https://doi.org/10.1378/chest.09-0370
- Hansell DM, Bankier AA, MacMahon H, McLoud TC, Muller NL, Remy J. Fleischner Society: glossary of terms for thoracic imaging. Radiology 2008;246:697-722 https://doi.org/10.1148/radiol.2462070712
- de Geus-Oei LF, van der Heijden HF, Visser EP, Hermsen R, van Hoorn BA, Timmer-Bonte JN, et al. Chemotherapy response evaluation with 18F-FDG PET in patients with nonsmall cell lung cancer. J Nucl Med 2007;48:1592-1598 https://doi.org/10.2967/jnumed.107.043414
- Hicks RJ, Kalff V, MacManus MP, Ware RE, Hogg A, McKenzie AF, et al. (18)F-FDG PET provides high-impact and powerful prognostic stratification in staging newly diagnosed non-small cell lung cancer. J Nucl Med 2001;42:1596-1604
- Takeuchi S, Khiewvan B, Fox PS, Swisher SG, Rohren EM, Bassett RL Jr, et al. Impact of initial PET/CT staging in terms of clinical stage, management plan, and prognosis in 592 patients with non-small-cell lung cancer. Eur J Nucl Med Mol Imaging 2014;41:906-914 https://doi.org/10.1007/s00259-013-2672-8
- Truong MT, Viswanathan C, Erasmus JJ. Positron emission tomography/computed tomography in lung cancer staging, prognosis, and assessment of therapeutic response. J Thorac Imaging 2011;26:132-146 https://doi.org/10.1097/RTI.0b013e3182128704
- Cerci JJ, Pereira Neto CC, Krauzer C, Sakamoto DG, Vitola JV. The impact of coaxial core biopsy guided by FDG PET/CT in oncological patients. Eur J Nucl Med Mol Imaging 2013; 40:98-103 https://doi.org/10.1007/s00259-012-2263-0
- Klaeser B, Wiskirchen J, Wartenberg J, Weitzel T, Schmid RA, Mueller MD, et al. PET/CT-guided biopsies of metabolically active bone lesions: applications and clinical impact. Eur J Nucl Med Mol Imaging 2010;37:2027-2036 https://doi.org/10.1007/s00259-010-1524-z
- Kim JI, Park CM, Kim H, Lee JH, Goo JM. Non-specific benign pathological results on transthoracic core-needle biopsy: how to differentiate false-negatives? Eur Radiol 2017;27: 3888-3895 https://doi.org/10.1007/s00330-017-4766-3
- Minot DM, Gilman EA, Aubry MC, Voss JS, Van Epps SG, Tuve DJ, et al. An investigation into false-negative transthoracic fine needle aspiration and core biopsy specimens. Diagn Cytopathol 2014;42:1063-1068 https://doi.org/10.1002/dc.23169
- Tsukada H, Satou T, Iwashima A, Souma T. Diagnostic accuracy of CT-guided automated needle biopsy of lung nodules. AJR Am J Roentgenol 2000;175:239-243 https://doi.org/10.2214/ajr.175.1.1750239
- Yeow KM, Tsay PK, Cheung YC, Lui KW, Pan KT, Chou AS. Factors affecting diagnostic accuracy of CT-guided coaxial cutting needle lung biopsy: retrospective analysis of 631 procedures. J Vasc Interv Radiol 2003;14:581-588. https://doi.org/10.1097/01.RVI.0000071087.76348.C7
- Heppner GH. Tumor heterogeneity. Cancer Res 1984;44: 2259-2265
- Miles KA, Williams RE. Warburg revisited: imaging tumour blood flow and metabolism. Cancer Imaging 2008;8:81-86 https://doi.org/10.1102/1470-7330.2008.0011
- Swanton C. Intratumor heterogeneity: evolution through space and time. Cancer Res 2012;72:4875-4882 https://doi.org/10.1158/0008-5472.CAN-12-2217
- Bar-Shalom R, Yefremov N, Guralnik L, Gaitini D, Frenkel A, Kuten A, et al. Clinical performance of PET/CT in evaluation of cancer: additional value for diagnostic imaging and patient management. J Nucl Med 2003;44:1200-1209
- Kubota K. From tumor biology to clinical PET: a review of positron emission tomography (PET) in oncology. Ann Nucl Med 2001;15:471-486 https://doi.org/10.1007/BF02988499
- Hua Q, Zhu X, Zhang L, Zhao Y, Tang P, Ni J. Initial experience with real-time hybrid single-photon emission computed tomography/computed tomography-guided percutaneous transthoracic needle biopsy. Nucl Med Commun 2017; 38:556-560 https://doi.org/10.1097/MNM.0000000000000675
- Aoki T, Tomoda Y, Watanabe H, Nakata H, Kasai T, Hashimoto H, et al. Peripheral lung adenocarcinoma: correlation of thin-section CT findings with histologic prognostic factors and survival. Radiology 2001;220:803-809 https://doi.org/10.1148/radiol.2203001701
- Lee HY, Lee KS. Ground-glass opacity nodules: histopathology, imaging evaluation, and clinical implications. J Thorac Imaging 2011;26:106-118 https://doi.org/10.1097/RTI.0b013e3181fbaa64
- Song YS, Park CM. Pulmonary subsolid nodules: an overview & management guidelines. J Korean Soc Radiol 2018;78:309-320 https://doi.org/10.3348/jksr.2018.78.5.309
- Hur J, Lee HJ, Nam JE, Kim YJ, Kim TH, Choe KO, et al. Diagnostic accuracy of CT fluoroscopy-guided needle aspiration biopsy of ground-glass opacity pulmonary lesions. AJR Am J Roentgenol 2009;192:629-634 https://doi.org/10.2214/AJR.08.1366
- Kim TJ, Lee JH, Lee CT, Jheon SH, Sung SW, Chung JH, et al. Diagnostic accuracy of CT-guided core biopsy of groundglass opacity pulmonary lesions. AJR Am J Roentgenol 2008; 190:234-239 https://doi.org/10.2214/AJR.07.2441
- Lu CH, Hsiao CH, Chang YC, Lee JM, Shih JY, Wu LA, et al. Percutaneous computed tomography-guided coaxial core biopsy for small pulmonary lesions with ground-glass attenuation. J Thorac Oncol 2012;7:143-150 https://doi.org/10.1097/JTO.0b013e318233d7dd
- Suh YJ, Lee JH, Hur J, Hong SR, Im DJ, Kim YJ, et al. Predictors of false-negative results from percutaneous transthoracic fine-needle aspiration biopsy: an observational study from a retrospective cohort. Yonsei Med J 2016;57:1243-1251 https://doi.org/10.3349/ymj.2016.57.5.1243
- American College of Radiology. Lung-RADSTM version 1.0 assessment categories. Available at: https://www.acr.org/-/media/ACR/Files/RADS/Lung-RADS/LungRADS_AssessmentCategories.pdf?la=en. Published Apr 28, 2014. Accessed Aug 25, 2017